Skip to search formSkip to main contentSkip to account menu

Insulin Analog [EPC]

Known as: Insulin Analog, Insulin Analogue 
National Institutes of Health

Related topics

Related topics

2 relations
Insulinanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort study
BackgroundRapid-acting insulin analogs (RAIs) have not been examined for long-term safety in randomized clinical trials. We… 
Review
2017
Review
2017
Administration of Biosimilar Insulin Analogs: Role of Devices.
With the expiration of patent protection for several originator insulin analog molecules, the availability of insulin analog… 
2014
2014
Enhanced insulin action following subcutaneous co‐administration of insulin and C‐peptide in rats
This study was undertaken to examine if C‐peptide (C) may interact with hexameric insulin and facilitate its disaggregation into… 
Review
2013
Review
2013
Insulin degludec: a long-acting modern insulin analogue with a predictable pharmacokinetic/pharmacodynamic profile.
Insulin degludec is, like insulin detemir, a product of coupling of Des-B30 threonine insulin to fatty acid side chains. After… 
2009
2009
Insulin glulisine in the management of diabetes
Insulin glulisine is appealing in principle, but the advantages of this drug over the other rapid-acting insulin analogs are… 
2007
2007
Overnight versus 24 Hours of Continuous Subcutaneous Insulin Infusion as Supplement to Oral Antidiabetic Drugs in Type 2 Diabetes
Background: Basal continuous subcutaneous insulin infusion (CSII) therapy at a fixed rate may effectively improve glycemic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)